Rocket Pharmaceuticals Inc (RCKT)
13.98
-0.84
(-5.67%)
USD |
NASDAQ |
Nov 15, 16:00
14.06
+0.08
(+0.57%)
After-Hours: 20:00
Rocket Pharmaceuticals Shareholders Equity (Quarterly): 329.77M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 329.77M |
| June 30, 2024 | 384.64M |
| March 31, 2024 | 441.50M |
| December 31, 2023 | 492.57M |
| September 30, 2023 | 541.09M |
| June 30, 2023 | 402.97M |
| March 31, 2023 | 458.88M |
| December 31, 2022 | 489.69M |
| September 30, 2022 | 367.31M |
| June 30, 2022 | 387.70M |
| March 31, 2022 | 417.62M |
| December 31, 2021 | 454.72M |
| September 30, 2021 | 485.66M |
| June 30, 2021 | 489.44M |
| March 31, 2021 | 480.00M |
| December 31, 2020 | 503.52M |
| September 30, 2020 | 241.84M |
| June 30, 2020 | 266.52M |
| March 31, 2020 | 286.05M |
| December 31, 2019 | 307.30M |
| September 30, 2019 | 231.92M |
| Date | Value |
|---|---|
| June 30, 2019 | 248.50M |
| March 31, 2019 | 177.08M |
| December 31, 2018 | 194.04M |
| September 30, 2018 | 143.62M |
| June 30, 2018 | 157.08M |
| March 31, 2018 | 170.15M |
| December 31, 2017 | 47.76M |
| September 30, 2017 | 51.08M |
| June 30, 2017 | 57.53M |
| March 31, 2017 | 63.26M |
| December 31, 2016 | 73.17M |
| September 30, 2016 | 85.05M |
| June 30, 2016 | 95.44M |
| March 31, 2016 | 99.24M |
| December 31, 2015 | 108.81M |
| September 30, 2015 | 116.48M |
| June 30, 2015 | 31.72M |
| March 31, 2015 | 33.95M |
| December 31, 2014 | -51.56M |
| September 30, 2014 | -0.316M |
| December 31, 2013 | -38.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
241.84M
Minimum
Sep 2020
541.09M
Maximum
Sep 2023
411.44M
Average
429.56M
Median
Shareholders Equity (Quarterly) Benchmarks
| Apellis Pharmaceuticals Inc | 237.12M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 393.69M |
| Total Liabilities (Quarterly) | 63.92M |